1972年8月生于内蒙古。1996年毕业于北京师范大学化学系物理化学专业，获理学硕士学位。2005年获得北京大学药剂学博士学位

现任北京大学药学院药剂学系副教授

主持或作为共同申请人负责国家自然科学基金资助项目3项

1. Xie Ying, Ye Liya, Zhang Xiaobin，Cui Wei, Lou Jinning, Tauneji Nagai, Hou Xinpu*. Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: In vitro and in vivo studies. J. Control. Release , 2005, 105(1-2):106-119.

2. Xie Ying, Wang Fei, Li Feifei, Li Dongsheng, Deng Lili, Effects of Binuclear Copper (II) Threonine Complex on Blood Glucose, Lipids and Protection of the Hearts and Kidneys in Diabetic Mice. J. Chin. Pharm. Sci ，2007, 16(1): 14-17.

3. Zheng T.-T.，Zhou H.-X.，Chen R.-Q.，Li Z-Y.，Xie Y. *，Jia H.-M.*. Improved Brain Uptake of 99mTcN-NOET loaded by Targeted Sterically Stabilized Liposomes in ICR Mice. J Label Compd Radiopharm , 2009, 52(S1):S80。

4. Zhou He-Xiang, Chen Rui-Qin, Sun Hui, Zhang Pei-Ran, Jia Hong-Mei*, Ying Xie*，Bio-distributions of [125I]Spiro-I brain targeted liposomes in mice， J. Chin. Pharm. Sci , 2010, 19(1): 47-51。

5. Zhang Pei-ran, Tu Ying-feng, Wang Shuo, Wang Yi-hui,Xie Ying *, Li Miao *, Jin Yiguang, Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery， J. Chin. Pharm. Sci, 2011, 20(4):390-396.

6. Sun Hui, Zhang Xian-Hua, Wang Shuo, Tu Ying-Feng, Zhao Rong-Sheng*, Xie Ying*. Preparation and characterization of oleanolic acid loaded solid lipid nanoparticles for oral administration, J. Chin. Pharm. Sci, 2011, 20(3):259-265.

7. Yu Yu-Ping , Wang Qi , Liu Ying-Chun*, Xie Ying*，Molecular basis for the targeted binding of RGD-containing peptide to integrin aVb3， Biomaterials , 2014, 35(5):1667-1675.[IF 8.312]

8. Luo Qi#,Wang Yihui#,Yang hongge, Liu Chang,Ding Yuan,Xu Haifeng,Wang Qi,Liu Yingchun*, Xie Ying*. ModelingtheInteractionofInterferonα-1b to Bovine SerumAlbuminas aDrugDeliverySystem. J Phys Chem B. 2014, 118(29):8566-8574. [IF 3.377]

9. Liu Chang#, Luo Qi#, Tu Ying-Feng, Wang Gui-Ling, Liu Ying-Chun*, Xie Ying*. Drug-carrier interaction analysis in the cell penetrating peptide-modified liposomes for doxorubicin loading. J Microencapsul .2015, 32(8):745-54. [IF 1.86]

10. Ding Yuan #, Sun Dan#, Wang Gui-Ling, Yang Hong-Ge, Xu Hai-Feng, Chen Jian-Hua*, Xie Ying*, Wang Zhi-Qiang. An efficient PEGylated liposomal nanocarrier containing cell penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Int J Nanomedicine . 2015, 10: 6199-6124. [IF 4.383]

11. Lin Shao-Hui, Cui Wei, Wang Gui-Ling, Meng Shuai, Liu Ying-Chun, Jin Hong-Wei, Zhang Liang-Ren, Xie Ying*, Combined computational and experimental studies of molecular interactions of albuterol sulfate with bovine serum albumin for pulmonary drug nanoparticles. Drug Des Devel Ther. 2016, 10: 2973-2987. [IF 2.822]

12. Liu Chang#, Liu Xiao-Na#, Wang Gui-Ling, Hei Yu, Meng Shuai, Yang Ling-Fei, Yuan Lan*, Xie Ying*, A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells, Int J Nanomedicine . 2017, 12: 2407-2425. [IF 4.300]

13. Ding Yuan#, Cui Wei#, Sun Dan, Wang Gui-Ling, Hei Yu, Meng Shuai, Chen Jian-Hua, Xie Ying*, Wang Zhi-Qiang. In vivo study of doxorubicin-loaded cell penetrating peptide modified pH sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/C-nude mice bearing human breast tumors. Drug Des Devel Ther . 2017, 11:3105-3117. [IF 2.822]

申请/授权专利10/4项